Oziltus
Oziltus ingredients
| Active ingredient | Strength |
|---|---|
| Denosumab | 70 mg/mL |
What Oziltus is used for
Oziltus is a specialist medicine (rank ligand inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Oziltus
- Generic name
- Denosumab-mobz
- Made by
- Amneal Pharmaceuticals LLC
- Forms
- Injection, Solution
- Given
- Subcutaneous
- Drug class
- RANK Ligand Inhibitor
- FDA approval
- Biologic licence (BLA) BLA761457
- On the US market since
- 2025
Official information
- MedlinePlus drug information (search for Denosumab-mobz)
In India
- Denosumab: 11 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Oziltus?
Oziltus (Denosumab-mobz) is a specialist medicine made by Amneal Pharmaceuticals LLC, approved by the US FDA.
What are the ingredients of Oziltus?
Oziltus contains Denosumab (70 mg/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA